These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 39303189)

  • 1. Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Final Results of the ORATOR Randomized Trial.
    Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Johnson-Obaseki S; Odell M; Corsten M; Parker C; Wehrli B; Kwan K; Palma DA
    J Clin Oncol; 2024 Dec; 42(34):4023-4028. PubMed ID: 39303189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial.
    Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Eapen L; Odell M; Parker C; Wehrli B; Kwan K; Palma DA
    Lancet Oncol; 2019 Oct; 20(10):1349-1359. PubMed ID: 31416685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial.
    Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Odell M; Parker C; Wehrli B; Kwan K; Palma DA
    J Clin Oncol; 2022 Mar; 40(8):866-875. PubMed ID: 34995124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early-stage squamous cell carcinoma of the oropharynx: radiotherapy vs. trans-oral robotic surgery (ORATOR)--study protocol for a randomized phase II trial.
    Nichols AC; Yoo J; Hammond JA; Fung K; Winquist E; Read N; Venkatesan V; MacNeil SD; Ernst DS; Kuruvilla S; Chen J; Corsten M; Odell M; Eapen L; Theurer J; Doyle PC; Wehrli B; Kwan K; Palma DA
    BMC Cancer; 2013 Mar; 13():133. PubMed ID: 23514246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term quality of life & functional outcomes after treatment of oropharyngeal cancer.
    Scott SI; Kathrine Ø Madsen A; Rubek N; Charabi BW; Wessel I; Fredslund Hadjú S; Jensen CV; Stephen S; Patterson JM; Friborg J; Hutcheson KA; Kehlet H; von Buchwald C
    Cancer Med; 2021 Jan; 10(2):483-495. PubMed ID: 33277795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of Life After Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharynx Cancer.
    Silver JA; Bouganim N; Richardson K; Henry M; Mascarella MA; Ramirez-GarciaLuna J; Golabi N; Mlynarek AM; Zeitouni A; Hier MP; Caglar D; Esfahani K; Sadeghi N
    JAMA Otolaryngol Head Neck Surg; 2024 Jan; 150(1):65-74. PubMed ID: 38060238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transoral Laser or Robotic Surgery Outcomes for Oropharyngeal Carcinoma: Secondary Analysis of the PATHOS Randomized Clinical Trial.
    O'Hara JT; Hurt CN; Ingarfield K; Patterson JM; Hutcheson K; Canham JE; Nixon LS; Heiberg CD; Johson S; Evans M; Jones TM
    JAMA Otolaryngol Head Neck Surg; 2024 Oct; 150(11):1002-11. PubMed ID: 39388196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of oropharyngeal squamous cell carcinoma: Is swallowing quality better after TORS or RT?
    Campo F; Iocca O; De Virgilio A; Mazzola F; Mercante G; Pichi B; Holsinger FC; Di Maio P; Ramella S; Pellini R
    Radiother Oncol; 2023 Jun; 183():109547. PubMed ID: 36813176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical Trial.
    Palma DA; Prisman E; Berthelet E; Tran E; Hamilton S; Wu J; Eskander A; Higgins K; Karam I; Poon I; Husain Z; Enepekides D; Hier M; Sultanem K; Richardson K; Mlynarek A; Johnson-Obaseki S; Odell M; Bayley A; Dowthwaite S; Jackson JE; Dzienis M; O'Neil J; Chandarana S; Banerjee R; Hart R; Chung J; Tenenholtz T; Krishnan S; Le H; Yoo J; Mendez A; Winquist E; Kuruvilla S; Stewart P; Warner A; Mitchell S; Chen J; Parker C; Wehrli B; Kwan K; Theurer J; Sathya J; Hammond JA; Read N; Venkatesan V; MacNeil SD; Fung K; Nichols AC
    JAMA Oncol; 2022 Jun; 8(6):1-7. PubMed ID: 35482348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.
    Howard J; Masterson L; Dwivedi RC; Riffat F; Benson R; Jefferies S; Jani P; Tysome JR; Nutting C
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010963. PubMed ID: 27943254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysphagia and QoL 3 Years After Treatment of Oropharyngeal Cancer With TORS or Radiotherapy.
    Scott SI; Madsen AKØ; Rubek N; Charabi BW; Wessel I; Jensen CV; Friborg J; von Buchwald C
    Laryngoscope; 2023 Aug; 133(8):1893-1898. PubMed ID: 36239625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival and Swallowing Function after Primary Radiotherapy versus Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
    Hughes RT; Levine BJ; May N; Shenker RF; Yang JH; Lanier CM; Frizzell BA; Greven KM; Waltonen JD
    ORL J Otorhinolaryngol Relat Spec; 2023; 85(5):284-293. PubMed ID: 37647863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life outcomes comparing primary Transoral Robotic Surgery (TORS) with primary radiotherapy for early-stage oropharyngeal squamous cell carcinoma: A systematic review and meta-analysis.
    Gupta KK; De M; Athanasiou T; Georgalas C; Garas G
    Eur J Surg Oncol; 2024 Jul; 50(7):108434. PubMed ID: 38795678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized decision support for selection of transoral robotic surgery or (chemo)radiation therapy based on posttreatment swallowing toxicity.
    Hemmati M; Barbon C; Mohamed ASR; van Dijk LV; Moreno AC; Gross ND; Goepfert RP; Lai SY; Hutcheson KA; Schaefer AJ; Fuller CD;
    Cancer Med; 2023 Feb; 12(4):5088-5098. PubMed ID: 36229990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysphagia After Primary Transoral Robotic Surgery With Neck Dissection vs Nonsurgical Therapy in Patients With Low- to Intermediate-Risk Oropharyngeal Cancer.
    Hutcheson KA; Warneke CL; Yao CMKL; Zaveri J; Elgohari BE; Goepfert R; Hessel AC; Kupferman ME; Lai SY; Fuller CD; Gunn GB; Garden AS; Johnson F; Ferrarotto R; Lewin JS; Gross ND;
    JAMA Otolaryngol Head Neck Surg; 2019 Nov; 145(11):1053-1063. PubMed ID: 31556933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Descriptive Study of Quality of Life Following Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
    Diaconescu A; Silver JA; Subramaniam T; Sewitch MJ; Mascarella MA; Ramirez-Garcia Luna J; Golabi N; Richardson K; Bouganim N; Forghani R; Marcin Mlynarek A; Hier MP; Sadeghi N
    J Otolaryngol Head Neck Surg; 2024; 53():19160216241248670. PubMed ID: 38888957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Return to work and self-reported swallowing following transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma: A retrospective cohort study.
    Staibano P; Au M; Xie M; Gupta MK; Young JEMT; Zhang H
    Oral Oncol; 2024 Dec; 159():107033. PubMed ID: 39278148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in Functional and Survival Outcomes Between Patients Receiving Primary Surgery vs Chemoradiation Therapy for Treatment of T1-T2 Oropharyngeal Squamous Cell Carcinoma.
    Amin DR; Philips R; Bertoni DG; Mastrolonardo EV; Campbell DJ; Agarwal AM; Tekumalla S; Urdang ZD; Luginbuhl AJ; Cognetti DM; Curry JM
    JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):980-986. PubMed ID: 37422846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus definitive chemoradiation.
    Ling DC; Chapman BV; Kim J; Choby GW; Kabolizadeh P; Clump DA; Ferris RL; Kim S; Beriwal S; Heron DE; Duvvuri U
    Oral Oncol; 2016 Oct; 61():41-6. PubMed ID: 27688103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating dysphagia and xerostomia outcomes following transoral robotic surgery for patients with oropharyngeal cancer.
    Mehta MP; Prince R; Butt Z; Maxwell BE; Carnes BN; Patel UA; Stepan KO; Mittal BB; Samant S
    Head Neck; 2021 Dec; 43(12):3955-3965. PubMed ID: 34617643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.